Prevalence of chemosensitive disorders with Omicron infections and the possible impacts of vaccination

Affiliations

• ¹ Young Otolaryngologists of International Federation of Otorhinolaryngological Societies, Paris, France; Maxillofacial Surgery Operative Unit, Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy; Biomedical Science Department, PhD School of Biomedical Science, University of Sassari, Sassari, Italy. Electronic address: lavaira@uniss.it.
• ² Maxillofacial Surgery Operative Unit, Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy; Biomedical Science Department, PhD School of Biomedical Science, University of Sassari, Sassari, Italy.
• ³ Young Otolaryngologists of International Federation of Otorhinolaryngological Societies, Paris, France; Otorhinolaryngology, Head and Neck Surgery Department, University Hospital Complex of A Coruña (CHUAC), A Coruña, Spain.
• ⁴ Young Otolaryngologists of International Federation of Otorhinolaryngological Societies, Paris, France; Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati Medical Center, Cincinnati, USA.
• ⁵ Young Otolaryngologists of International Federation of Otorhinolaryngological Societies, Paris, France; Department of Laryngology and Bronchoesophagology, EpiCURA Hospital, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium; Department of Otolaryngology-Head & Neck Surgery, Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France.